Clinical Trial

Acapella vs Flutter Devices for Improving Breathing and Lung Function After Lobectomy

Recruiting
View on ClinicalTrials.gov →
Summary
Lobectomy patients frequently experience postoperative respiratory complications such as secretion retention, dyspnea, impaired gas exchange, and reduced lung function, which can delay recovery. Oscillatory Positive Expiratory Pressure (OPEP) devices such as Acapella and Flutter are commonly used to improve airway clearance and pulmonary function. This study aims to compare the effects of Acapella and Flutter devices on secretion clearance, dyspnea, arterial blood gases, and lung function in post-lobectomy patients.
Trial Details
NCT Number NCT07737093
Lead Sponsor Riphah International University
Conditions Lobotomy Syndrome
Enrollment 28 participants
Start Date 2026-06-20
Primary Completion 2026-11-15 (estimated)
Study Completion 2026-12-15 (estimated)
Updated on ClinicalTrials.gov 2026-07-30